Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis

Arthritis and Rheumatism

Volumn 64, Issue 11, 2012, Pages 3583-3593

  Galligan, Carole L ^a   Fish, Eleanor N ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX METALLOPROTEINASE; PROTEIN KINASE B; STAT1 PROTEIN; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CELL MIGRATION; CELL TRANSFER; CELL TYPE; COLLAGEN ANTIBODY INDUCED ARTHRITIS; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROCYTE; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; CELL MOVEMENT; CELL SEPARATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBROBLASTS; JOINTS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED DBA; MULTIPOTENT STEM CELLS; NEUTROPHILS; STEM CELL TRANSPLANTATION; SYNOVIAL MEMBRANE;

EID: 84868112181     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34589     Document Type: Article

References (53)

1. Gabriel SE,. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-81.
2. Klareskog L, Malmstrom V, Lundberg K, Padyukov L, Alfredsson L,. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011; 23: 92-8.
3. Schett G, Firestein GS,. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 2010; 69: 787-9.
4. Nykanen P, Helve T, Kankaanpaa U, Larsen A,. Characterization of the DNA-synthesizing cells in rheumatoid synovial tissue. Scand J Rheumatol 1978; 7: 118-22.
5. Jacobs RA, Perrett D, Axon JM, Herbert KE, Scott DL,. Rheumatoid synovial cell proliferation, transformation and fibronectin secretion in culture. Clin Exp Rheumatol 1995; 13: 717-23.
6. Tsumuki H, Hasunuma T, Kobata T, Kato T, Uchida A, Nishioka K,. Basic FGF-induced activation of telomerase in rheumatoid synoviocytes. Rheumatol Int 2000; 19: 123-8.
7. Young A, Koduri G,. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 907-27.
8. Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009; 15: 1414-20.
9. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A,. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
10. Herzog EL, Bucala R,. Fibrocytes in health and disease. Exp Hematol 2010; 38: 548-56.
11. Galligan CL, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, Fish EN,. Fibrocyte activation in rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 640-51.
12. Peters LL, Barker JE,. Hematology and clotting time survey in 43 inbred strains of mice. 2001. MPD:Peters1. Mouse phenome database at The Jackson Laboratory, Bar Harbor, Maine. URL: http://phenome.jax.org/db/q?rtn=projects/ details&sym=Peters.
13. Nandakumar KS, Svensson L, Holmdahl R,. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003; 163: 1827-37.
14. Zhu P, Lu N, Shi ZG, Zhou J, Wu ZB, Yang Y, et al. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis Res Ther 2006; 8: R44.
15. Pozgan U, Caglic D, Rozman B, Nagase H, Turk V, Turk B,. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Biol Chem 2010; 391: 571-9.
16. Schindler C, Levy DE, Decker T,. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282: 20059-63.
17. Han L, Wierenga AT, Rozenveld-Geugien M, van de Lande K, Vellenga E, Schuringa JJ,. Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses. PLoS One 2009; 4: e7989.
18. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114: 438-46.
19. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009; 60: 813-23.
20. Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007; 56: 1076-86.
21. De Klerck B, Geboes L, Hatse S, Kelchtermans H, Meyvis Y, Vermeire K, et al. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res Ther 2005; 7: R1208-20.
22. Yang MH, Wu FX, Xie CM, Qing YF, Wang GR, Guo XL, et al. Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication. Chin Med Sci J 2009; 24: 50-4.
23. Boiardi L, Macchioni P, Meliconi R, Pulsatelli L, Facchini A, Salvarani C,. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol 1999; 17: 419-25.
24. Page G, Miossec P,. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J Pathol 2004; 204: 28-38.
25. Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S,. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010; 62: 383-91.
26. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992; 90: 772-9.
27. Iwamoto T, Okamoto H, Toyama Y, Momohara S,. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008; 275: 4448-55.
28. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN,. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-62.
29. Reines BP,. Is rheumatoid arthritis premature osteoarthritis with fetal-like healing? Autoimmun Rev 2004; 3: 305-11.
30. Chesney J, Bacher M, Bender A, Bucala R,. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997; 94: 6307-12.
31. Galligan CL, Pennell LM, Murooka TT, Baig E, Majchrzak-Kita B, Rahbar R, et al. Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis. Mult Scler 2011; 16: 1458-73.
32. Wang Y, Kai H, Chang F, Shibata K, Tahara-Hanaoka S, Honda S, et al. A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis. Biochem Biophys Res Commun 2007; 353: 857-62.
33. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H,. T lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985; 22: 295-306.
34. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R,. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004; 6: R544-50.
35. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001; 15: 2215-24.
36. Mulherin D, FitzGerald O, Bresnihan B,. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115-24.
37. Wright HL, Moots RJ, Bucknall RC, Edwards SW,. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010; 49: 1618-31.
38. Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D,. Macrophages in rheumatoid arthritis. Histol Histopathol 2007; 22: 581-6.
39. Cross A, Bucknall RC, Cassatella MA, Edwards SW, Moots RJ,. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum 2003; 48: 2796-806.
40. Schett G, Zwerina J, Firestein G,. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 2008; 67: 909-16.
41. Thalhamer T, McGrath MA, Harnett MM,. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 2008; 47: 409-14.
42. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
43. De Launay D, van de Sande MG, de Hair MJ, Grabiec AM, van de Sande GP, Lehmann KA, et al. Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared with 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets. Ann Rheum Dis 2012; 71: 415-23.
44. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108: 73-81.
45. Ratajczak-Wrona W, Jablonska E, Garley M, Jablonski J, Radziwon P,. Effect of N-nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: the role of JNK signalling pathway. APMIS 2011; 119: 431-41.
46. Svensson CI, Inoue T, Hammaker D, Fukushima A, Papa S, Franzoso G, et al. Gadd45β deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling. Arthritis Rheum 2009; 60: 3229-40.
47. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R,. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998; 160: 419-25.
48. Martel-Pelletier J, Welsch DJ, Pelletier JP,. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001; 15: 805-29.
49. Andersen TL, del Carmen Ovejero M, Kirkegaard T, Lenhard T, Foged NT, Delaisse JM,. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. Bone 2004; 35: 1107-19.
50. Tetta C, Camussi G, Modena V, Di Vittorio C, Baglioni C,. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. Ann Rheum Dis 1990; 49: 665-7.
51. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW,. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 2: 706-9.
52. Yu Q, Stamenkovic I,. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-76.
53. Garcia-de-Alba C, Becerril C, Ruiz V, Gonzalez Y, Reyes S, Garcia-Alvarez J, et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 2010; 182: 1144-52.